Risk and timing of clinical events according to diabetic status of patients treated with Everolimus-Eluting Bioresorbable Vascular Scaffolds vs. Everolimus-Eluting stent: 2-Year results from a propensity score matched comparison of ABSORB EXTEND and SPIRIT trials

被引：1

作者：

Campos, Carlos ^{[1
]}

Abizaid, Alexandre ^{[2
]}

Caixeta, Adriano ^{[3
]}

Bartorelli, Antonio ^{[4
]}

Whitbourn, Robert ^{[5
]}

Perin, Marco ^{[6
]}

机构：

[1] Incor, Sao Paulo, Brazil

[2] Inst Dante Pazzanese Cardiol, Sao Paulo, Brazil

[3] Hosp Israelita Albert Einstein, Sao Paulo, Brazil

[4] Univ Milan, Milan, Italy

[5] St Vincent Hosp Melbourne, Melbourne, Vic, Australia

[6] Hosp Albert Einstein, Sao Paulo, Brazil

来源：

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2016年 / 68卷 / 18期

关键词：

D O I：

10.1016/j.jacc.2016.09.546

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

TCT-411

引用

页码：B167 / B167

页数：1

共 50 条

[1] Risk and timing of clinical events according to diabetic status of patients treated with everolimus-eluting bioresorbable vascular scaffolds versus everolimus-eluting stent: 2-year results from a propensity score matched comparison of ABSORB EXTEND and SPIRIT trials
Campos, Carlos M.
Caixeta, Adriano
Franken, Marcelo
Bartorelli, Antonio L.
Whitbourn, Robert J.
Wu, Chiung-Jen
Kao, Hsien Li Paul
Ali, Rosli Mohd
Carrie, Didier
De Bruyne, Bernard
Stone, Gregg W.
Serruys, Patrick W.
Abizaid, Alexandre
[J]. CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2018, 91 (03) : 387 - 395
[2] One-year clinical outcomes of patients treated with everolimus-eluting bioresorbable vascular scaffolds versus everolimus-eluting metallic scents: a propensity score comparison of patients enrolled in the ABSORB EXTEND and SPIRIT trials
Costa, Jose de Ribamar, Jr.
Abizaid, Alexandre
Bartorelli, Antonio L.
Whitbourn, Robert
Jepson, Nigel
Perin, Marco
Steinwender, Clemens
Stuteville, Marrianne
Ediebah, Divine
Sudhir, Krishnankutty
Serruys, Patrick W.
[J]. EUROINTERVENTION, 2016, 12 (10) : 1255 - 1262
[3] LONG-TERM OUTCOMES OF PATIENTS TREATED WITH EVEROLIMUS-ELUTING BIORESORBABLE VASCULAR SCAFFOLDS VERSUS EVEROLIMUS-ELUTING METALLIC STENTS: A PROPENSITY SCORE COMPARISON OF PATIENTS ENROLLED IN THE ABSORB EXTEND AND SPIRIT TRIALS
Costa, Jose de Ribamar
Abizaid, Alexandre
[J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (13) : 430 - 430
[4] FINAL 3-YEAR CLINICAL OUTCOMES OF PATIENTS TREATED WITH EVEROLIMUS-ELUTING BIORESORBABLE SCAFFOLDS VERSUS EVEROLIMUS-ELUTING METALLIC STENTS: A PROPENSITY SCORE COMPARISON OF PATIENTS ENROLLED IN THE EXTEND AND SPIRIT TRIALS
Costa, Jose de Ribamar
Abizaid, Alexandre
Bartorelli, Antonio
Whitbourn, Robert
Serruys, Patrick
[J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (11) : 971 - 971
[5] Three-year clinical outcomes of patients treated with everolimus-eluting bioresorbable vascular scaffolds: Final results of the ABSORB EXTEND trial
Ribamar Costa, J., Jr.
Abizaid, Alexandre
Whitbourn, Robert
Serruys, Patrick W.
Jepson, Nigel
Steinwender, Clemens
Stuteville, Marrianne
Ediebah, Divine
Sudhir, Krishnankutty
Bartorelli, Antonio L.
[J]. CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2019, 93 (01) : E1 - E7
[6] One-year Clinical Outcomes of Diabetic Patients Treated With Everolimus-Eluting Bioresorbable Vascular Scaffolds: A Pooled Analysis From the ABSORB Cohort B and the ABSORB EXTEND Trials.
Muramatsu, Takashi
Onuma, Yoshinobu
Van Geuns, Robert J.
Chevalier, Bernard
Patel, Tejas M.
Seth, Ashok
Diletti, Roberto
Garcia-Garcia, Hector M.
Dorange, Cecile
Veldhof, Susan
Cheong, Wai-Fung
Whitbourn, Robert J.
Bartorelli, Antonio L.
Abizaid, Alexandre
Serruys, Patrick W.
[J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 62 (18) : B12 - B13
[7] 1-Year Clinical Outcomes of Diabetic Patients Treated With Everolimus-Eluting Bioresorbable Vascular Scaffolds
Muramatsu, Takashi
Onuma, Yoshinobu
van Geuns, Robert-Jan
Chevalier, Bernard
Patel, Tejas M.
Seth, Ashok
Diletti, Roberto
Garcia-Garcia, Hector M.
Dorange, Cecile C.
Veldhof, Susan
Cheong, Wai-Fung
Ozaki, Yukio
Whitbourn, Robert
Bartorelli, Antonio
Stone, Gregg W.
Abizaid, Alexandre
Serruys, Patrick W.
[J]. JACC-CARDIOVASCULAR INTERVENTIONS, 2014, 7 (05) : 482 - 493
[8] Short and Mid-Term Outcomes of Diabetic Patients Treated with Everolimus-Eluting Bioresorbable Scaffolds Versus Second-Generation Drug Eluting Stents: a Propensity Score-Matched Analysis of ABSORB EXTEND and SPIRIT Clinical Trials
Campos, Carlos M.
Abizaid, Alexandre
Caixeta, Adriano
Bartorelli, Antonio L.
Whitbourn, Robert J.
Perin, Marco A.
[J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 66 (15) : B244 - B245
[9] ABSORB bioresorbable vascular scaffold vs. everolimus-eluting metallic stent in ST-segment elevation myocardial infarction (BVS EXAMINATION study): 2-year results from a propensity score matched comparison
Brugaletta, Salvatore
Gori, Tommaso
Low, Adrian
Tousek, Petr
Pinar Bermudez, Eduardo
Gomez Lara, Josep
Ortega-Paz, Luis
Schulz, Eberhard
Chan, Mark
Kocka, Viktor
Hurtado, Jose
Antoni Gomez-Hospital, Joan
Muenzel, Thomas
Lee, Chi-Hang
Cequier, Angel
Valdes, Mariano
Widimsky, Petr
Serruys, Patrick
Sabate, Manel
[J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 68 (18) : B164 - B164
[10] ABSORB bioresorbable vascular scaffold vs. everolimus-eluting metallic stent in ST-segment elevation myocardial infarction (BVS EXAMINATION study): 2-Year results from a propensity score matched comparison
Brugaletta, Salvatore
Gori, Tommaso
Low, Adrian F.
Tousek, Petr
Pinar, Eduardo
Gomez-Lara, Josep
Ortega-Paz, Luis
Schulz, Eberhard
Chan, Mark Y.
Kocka, Viktor
Hurtado, Jose
Antoni Gomez-Hospital, Joan
Giacchi, Giuseppe
Muenzel, Thomas
Lee, Chi-Hang
Cequier, Angel
Valdes, Mariano
Widimsky, Petr
Serruys, Patrick W.
Sabate, Manel
[J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 214 : 484 - 485

← 1 2 3 4 5 →